[HTML][HTML] Minimally invasive local therapies for liver cancer
D Li, J Kang, BJ Golas, VW Yeung… - Cancer biology & …, 2014 - ncbi.nlm.nih.gov
Primary and metastatic liver tumors are an increasing global health problem, with
hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related mortality …
hepatocellular carcinoma (HCC) now being the third leading cause of cancer-related mortality …
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
…, S Mehandru, BJ Golas, D Labow, J Sfakianos… - Nature medicine, 2022 - nature.com
Window-of-opportunity trials, during which patients receive short-duration pre-surgical
therapies, provide a platform for understanding the therapies' mechanisms of action, but will …
therapies, provide a platform for understanding the therapies' mechanisms of action, but will …
[HTML][HTML] Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver …
I Sucandy, S Cheek, BJ Golas, A Tsung, DA Geller… - Hpb, 2016 - Elsevier
Background We aim to investigate long-term survival outcomes in patients undergoing
radiofrequency ablation (RFA), based on our longitudinal 5 and 10 year follow-up data. Methods …
radiofrequency ablation (RFA), based on our longitudinal 5 and 10 year follow-up data. Methods …
Surveillance of low-grade appendiceal mucinous neoplasms with peritoneal metastases after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
…, J Carr, S Ballentine, DR Magge, BJ Golas… - Annals of Surgical …, 2020 - Springer
Background Low-grade appendiceal mucinous neoplasms (LAMNs) are tumors that often
present with widespread mucin in the peritoneal cavity (pseudomyxoma peritonei [PMP]). …
present with widespread mucin in the peritoneal cavity (pseudomyxoma peritonei [PMP]). …
Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated …
…, D Feingold, PH Liu, S Aycart, BJ Golas… - Journal of Surgical …, 2019 - Wiley Online Library
Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
is effective in select patients with peritoneal carcinomatosis (PC). Signet ring cell (SRC…
is effective in select patients with peritoneal carcinomatosis (PC). Signet ring cell (SRC…
[HTML][HTML] Staging gallbladder cancer with lymphadenectomy: the practical application of new AHPBA and AJCC guidelines
…, SP Hiotis, DM Labow, DR Magge, U Sarpel, BJ Golas - HPB, 2019 - Elsevier
Background Current guidelines recommend harvesting a total lymph node count (TLNC) ≥6
from portal lymphadenectomy in ≥pT1b gallbladder cancers (GBC) for accurate staging …
from portal lymphadenectomy in ≥pT1b gallbladder cancers (GBC) for accurate staging …
Actual 5-year survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis of colorectal origin
…, N Khajoueinejad, AT Yu, S Hiotis, BJ Golas… - Annals of Surgical …, 2024 - Springer
Background Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC)
improves survival compared with chemotherapy alone in patients with peritoneal …
improves survival compared with chemotherapy alone in patients with peritoneal …
SCCRO promotes glioma formation and malignant progression in mice
Originally identified as an oncogene activated by amplification in squamous cell carcinomas,
several lines of evidence now suggest that squamous cell carcinoma-related oncogene (…
several lines of evidence now suggest that squamous cell carcinoma-related oncogene (…
Improved survival with experience: a 10-year learning curve in hyperthermic intraperitoneal chemotherapy and cytoreductive surgery
…, D Solomon, D Feingold, DR Magge, BJ Golas… - Annals of Surgical …, 2020 - Springer
Background Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
is an aggressive locoregional treatment for peritoneal carcinomatosis (PC). Studies …
is an aggressive locoregional treatment for peritoneal carcinomatosis (PC). Studies …
Hepatitis C‐positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype
…, J Carr, ER Pletcher, NA Cohen, BJ Golas… - Cancer, 2021 - Wiley Online Library
Background In the United States, mortality after a diagnosis of hepatocellular carcinoma (HCC)
is higher in patients who are Black than in patients of other racial groups. The objective of …
is higher in patients who are Black than in patients of other racial groups. The objective of …
